Loading...
Keywords
Last Name
Institution

Joy M. Fulbright, MD

TitleDirector, Adolescent and Young Adult Program
InstitutionChildren's Mercy Kansas City
DepartmentPediatrics
Address2401 Gillham Rd
Kansas City MO 64108
vCardDownload vCard
    Other Positions
    TitleDirector, Survive and Thrive Program
    InstitutionChildren's Mercy Kansas City
    DepartmentPediatrics

    TitleAssociate Professor of Pediatrics
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPediatrics

    TitleClinical Assistant Professor of Pediatrics
    InstitutionUniversity of Kansas Medical Center
    DepartmentPediatrics


    Collapse Biography 
    Collapse education and training
    University of Missouri-Columbia School of Medicine, Columbia, MOMD
    Good Samaritan HosptialResidencyInternal Medicine/Pediatrics
    Anderson Cancer Center, University of Texas, Houston, TXFellowshipPediatric Hematology/Oncology

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Toro C, Felmingham B, Jhadav M, Celermajer DS, La Gerche A, O'Sullivan J, Kumar S, Mateos MK, Fulbright J, Govender D, Collier L, Cheung M, Eisenstat DD, Lange PW, Ayer J, Elliott DA, Conyers R. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic. Cardiooncology. 2023 Dec 07; 9(1):45. PMID: 38062530.
      View in: PubMed
    2. Dargan C, Mc Dermott S, Chesbro S, Trout A, Terwilliger N, Hilyard T, Flynn A, Fulbright J. Standardization of Fertility Preservation Discussion Among Pediatric Oncology and Bone Marrow Transplant Patients: A Single Institution Experience. J Adolesc Young Adult Oncol. 2023 04; 12(2):259-265. PMID: 35675684.
      View in: PubMed
    3. Shah K, Fulbright J, Katz A, Zhang L, Jarka D, Lypka M. Malignant Granular Cell Tumor of the Lower Extremity in an Adolescent Male. J Pediatr Hematol Oncol. 2021 05 01; 43(4):e529-e531. PMID: 32769557.
      View in: PubMed
    4. Ehrhardt MJ, Ward ZJ, Liu Q, Chaudhry A, Nohria A, Border W, Fulbright JM, Mulrooney DA, Oeffinger KC, Nathan PC, Leisenring WM, Constine LS, Gibson TM, Chow EJ, Howell RM, Robison LL, Armstrong GT, Hudson MM, Diller L, Yasui Y, Armenian SH, Yeh JM. Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer. J Clin Oncol. 2020 11 20; 38(33):3851-3862. PMID: 32795226.
      View in: PubMed
    5. Fulbright JM, Hein W, Stegenga K, Alsman K, Sharma M, Ryan R, Klemp JR, Nelson EL, Raman S. Implementing a stepwise educational approach for bridging the gap between specialty and primary care for childhood cancer survivors. J Cancer Surviv. 2020 10; 14(5):660-665. PMID: 32394044.
      View in: PubMed
    6. August KJ, Farooki S, Fulbright JM, August A, Portnoy JM, Pommert L, Burke MJ, Guest EM. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma. Pediatr Blood Cancer. 2020 01; 67(1):e28021. PMID: 31571395.
      View in: PubMed
    7. Rentea RM, Poola AS, Fulbright JM, St Peter SD, Shah SR. Utility of pediatric female fertility preservation discussions following pelvic radiation. Pediatr Surg Int. 2018 Jun; 34(6):647-651. PMID: 29619566.
      View in: PubMed
    8. Parrales A, McDonald P, Ottomeyer M, Roy A, Shoenen FJ, Broward M, Bruns T, Thamm DH, Weir SJ, Neville KA, Iwakuma T, Fulbright JM. Comparative oncology approach to drug repurposing in osteosarcoma. PLoS One. 2018; 13(3):e0194224. PMID: 29579058.
      View in: PubMed
    9. Shah SS, McClellan W, Knowlton JQ, Mehta J, Goudar S, Ferguson A, Sherman A, Shirali G, Fulbright J. Medium-term assessment of cardiac function in pediatric cancer survivors. Comparison of different echocardiographic methods, cardiac MRI and cardiac biomarker testing in adolescent cancer survivors. Echocardiography. 2017 Feb; 34(2):250-256. PMID: 27996161.
      View in: PubMed
    10. Ehrhardt MJ, Fulbright JM, Armenian SH. Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future. Curr Oncol Rep. 2016 Apr; 18(4):22. PMID: 26922328.
      View in: PubMed
    11. Fulbright JM, Williams SE, Pahud BA. Immune Thrombocytopenic Purpura Following Postexposure Rabies Prophylaxis. J Pediatr Hematol Oncol. 2016 Mar; 38(2):165. PMID: 26808372.
      View in: PubMed
    12. Fulbright JM, Egas-Bejar DE, Huh WW, Chandra J. Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy. Cancer Chemother Pharmacol. 2015 Dec; 76(6):1297-307. PMID: 26515054.
      View in: PubMed
    13. Fulbright JM, Williams SE, Pahud BA. A Case of Immune Thrombocytopenic Purpura After Rabies Vaccination. J Pediatr Hematol Oncol. 2015 Oct; 37(7):e427-8. PMID: 26165405.
      View in: PubMed
    14. McClellan W, Fulbright JM, Doolittle GC, Alsman K, Klemp JR, Ryan R, Nelson EL, Stegenga K, Krebill H, Al-hihi EM, Schuetz N, Heiman A, Lowry B. A Collaborative Step-Wise Process to Implementing an Innovative Clinic for Adult Survivors of Childhood Cancer. J Pediatr Nurs. 2015 Sep-Oct; 30(5):e147-55. PMID: 26202467.
      View in: PubMed
    15. Villanueva M, Fulbright JM, Horii KA. Phototherapy induced cutaneous eruption in a neonate with transient porphyrinemia. J Neonatal Perinatal Med. 2015; 8(4):417-20. PMID: 26836825.
      View in: PubMed
    16. Ehrhardt MJ, Armenian SH, Fulbright JM. Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors. Future Oncol. 2015; 11(14):2031-4. PMID: 26198832.
      View in: PubMed
    17. Radhi M, Fulbright JM, Ginn KF, Guest EM. Childhood cancer for the primary care physician. Prim Care. 2015 Mar; 42(1):43-55. PMID: 25634704.
      View in: PubMed
    18. Kesselheim JC, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Garvey K, Kersun L, Nageswara Rao A, Reilly A, Sharma M, Shereck E, Wang M, Watt T, Leavey P. Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training. Pediatr Blood Cancer. 2015 02; 62(2):335-340. PMID: 25307425.
      View in: PubMed
    19. Vijapura CA, Fulbright JM. Use of radiation in treatment of central nervous system juvenile xanthogranulomatosis. Pediatr Hematol Oncol. 2012 Aug; 29(5):440-5. PMID: 22712784.
      View in: PubMed
    20. Fulbright JM, Raman S, McClellan WS, August KJ. Late effects of childhood leukemia therapy. Curr Hematol Malig Rep. 2011 Sep; 6(3):195-205. PMID: 21695425.
      View in: PubMed
    21. Fulbright JM. Review of cardiotoxicity in pediatric cancer patients: during and after therapy. Cardiol Res Pract. 2011; 2011:942090. PMID: 21637324.
      View in: PubMed
    22. Fulbright JM, Huh W, Anderson P, Chandra J. Can anthracycline therapy for pediatric malignancies be less cardiotoxic? Curr Oncol Rep. 2010 Nov; 12(6):411-9. PMID: 20820959.
      View in: PubMed
    23. Rivera-Del Valle N, Gao S, Miller CP, Fulbright J, Gonzales C, Sirisawad M, Steggerda S, Wheler J, Balasubramanian S, Chandra J. PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells. Int J Cell Biol. 2010; 2010:207420. PMID: 20145726.
      View in: PubMed
    Fulbright's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (147) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department